Gilead Slams Merck's Bid To Boost $200M Award In IP Row
Gilead Sciences on Tuesday urged a California federal judge to reject Merck's request for millions in supplemental damages and pre-judgment interest on top of the $200 million that a jury said...To view the full article, register now.
Already a subscriber? Click here to view full article